The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Fri., Dec. 6, 8:35 PM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #66. BioTelemetry, Inc. Cardiac Patient Services Business of Biomedical Systems, Corp.

Acquirer: BioTelemetry, Inc. (NASDAQ:BEAT)
Acquiree: Cardiac Patient Services Business of Biomedical Systems, Corp.
Details: BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced that it has entered into a definitive agreement to acquire the cardiac patient services business of Biomedical Systems, Corp. ("BMS") for aggregate consideration of $8.65 million at closing. Post integration, the acquisition is expected to generate $8.0 to $9.0 million in revenue and $2.5 to $3.0 million in EBITDA on an annualized basis. The transaction is expected to close in early April.

BioTelemetry is a remote medical technology company focused on delivery of health information. Co. provides remote cardiac monitoring, remote blood glucose monitoring, centralized core lab services for clinical trials and original equipment manufacturing that serves both healthcare and clinical research customers. Co. operates under two reportable segments: Healthcare, which is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders; and Research, which is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials.

BEAT SEC Filing Email Alerts Service


Open the BEAT Page at The Online Investor »

Company Name: 
BioTelemetry Inc
Sector: 
Diagnostics
Number of ETFs Holding BEAT: 
33
Total Market Value Held by ETFs: 
$334.01M
Total Market Capitalization: 
$1.59B
% of Market Cap. Held by ETFs: 
21.06%
 

Open the BEAT Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Buy (3.25 out of 4)
50th percentile
(ranked higher than approx. 50% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 66 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.